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Abstract
Background—Patient-centered health care interventions, such as heart failure disease management
programs, are under increasing pressure to demonstrate good value. Variability in costing methods and
assumptions in economic evaluations of such interventions limit the comparability of cost estimates across
studies. Valid cost estimation is critical to conducting economic evaluations and for program budgeting and
reimbursement negotiations.
Methods and Results—Using sound economic principles, we developed the Tools for Economic Analysis of
Patient Management Interventions in Heart Failure (TEAM-HF) Costing Tool, a spreadsheet program that
can be used by researchers and health care managers to systematically generate cost estimates for economic
evaluations and to inform budgetary decisions. The tool guides users on data collection and cost assignment
for associated personnel, facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up
activities. The tool generates estimates of total program costs, cost per patient, and cost per week and presents
results using both standardized and customized unit costs for side-by-side comparisons. Results from pilot
testing indicated that the tool was well-formatted, easy to use, and followed a logical order. Cost estimates of a
12-week exercise training program in patients with heart failure were generated with the costing tool and were
found to be consistent with estimates published in a recent study.
Conclusions—The TEAM-HF Costing Tool could prove to be a valuable resource for researchers and health
care managers to generate comprehensive cost estimates of patient-centered interventions in heart failure or
other conditions for conducting high-quality economic evaluations and making well-informed health care
management decisions.
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Abstract
Background—Patient-centered health care interventions, such as heart failure disease
management programs, are under increasing pressure to demonstrate good value. Variability in
costing methods and assumptions in economic evaluations of such interventions limit the
comparability of cost estimates across studies. Valid cost estimation is critical to conducting
economic evaluations and for program budgeting and reimbursement negotiations.
Methods and Results—Using sound economic principles, we developed the Tools for
Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-HF) Costing
Tool, a spreadsheet program that can be used by researchers or health care managers to
systematically generate cost estimates for economic evaluations and to inform budgetary
decisions. The tool guides users on data collection and cost assignment for associated personnel,
facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up activities. The
tool generates estimates of total program costs, cost per patient, and cost per week and presents
results using both standardized and customized unit costs for side-by-side comparisons. Results
from pilot testing indicated that the tool was well-formatted, easy to use, and followed a logical
order. Cost estimates of a 12-week exercise training program in patients with heart failure were
generated with the costing tool and were found to be consistent with estimates published in a
recent study.
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Conclusions—The TEAM-HF Costing Tool could prove to be a valuable resource for
researchers and health care managers to generate comprehensive cost estimates of patient-centered
interventions in heart failure or other conditions for conducting high-quality economic evaluations
and making well-informed health care management decisions.
Keywords
Computing Methodologies; Disease Management; Health Care Costs
Introduction
Patient-centered health care interventions, such as heart failure disease management
programs, are under increasing pressure to demonstrate good value as health care budgets
are further scrutinized for inefficiency. High-quality cost estimates are important to health
care managers for budgetary decision making, setting payment rates, negotiating
reimbursement contracts, forecasting costs with program expansion or contraction, and
identifying ways to improve program efficiency. In research settings, there is also a growing
demand for economic evaluations that provide accurate and standardized cost estimates so
that national and international bodies, professional societies, and managed care
organizations can make informed guidelines and recommendations.1-7
The general lack of detail regarding cost-estimation methods in published studies of patient-
focused interventions like cardiac rehabilitation, disease management interventions, and
other programs targeting patients with chronic conditions suggests that there has been little
standardization of costing methods.8-19 The available information suggests that program
costs are systematically underestimated. Some studies report on savings induced by the
programs but do not include the cost of the intervention,20-22 and others limit cost estimation
to personnel time devoted to providing the intervention without consideration of overhead or
other fixed or variable costs.9,13-15 Some analysts have applied reimbursement rates for
similar services as a proxy,23 and some have applied fees paid to or charges from the
companies that provide the intervention.24-26 Although the latter strategy may represent the
appropriate cost from the payer’s perspective, this strategy may lead to poor decision
making by the provider or broader national decision-making bodies, because fees or charges
can misrepresent the resources actually devoted to the intervention.27,28
Much of the literature has focused on heart failure, for which expenditures are massive.29
More than 4 million Medicare beneficiaries have heart failure, and more than one-quarter of
patients with heart failure die within 1 year.30 With more than 60% of expenditures
attributable to inpatient care,29 providers have long recognized the potential economic
savings of programs designed to reduce hospital admissions among patients with heart
failure.
Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-
HF) consists of 2 projects. The first project is the development of a costing tool designed to
assist with estimating costs of patient-focused interventions in heart failure or other
conditions. The second project aims to develop a customizable computer model to estimate
the long-term cost-effectiveness of patient-focused interventions in heart failure. In this
paper, we report on the development of the first project, the TEAM-HF Costing Tool. Then,
we compare estimates of the cost of an exercise training program for patients with heart
failure patients derived from the costing tool with cost estimates reported in a recently
published economic evaluation of exercise training.9 Lastly, we describe the potential uses
of the tool and discuss its strengths and limitations.
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Methods
Determining the cost of a medical intervention requires consideration of the study
perspective and time horizon. The study perspective is critical for determining which
resources should be included and how they should be valued.27,28 A study can take one or
multiple perspectives depending on the objectives of the study. The societal perspective is
generally recommended, but other perspectives, such as payer, patient, and provider may
also be of interest. If an economic evaluation (eg, cost comparison, cost-effectiveness
analysis) is performed from the societal perspective, all resources incurred in the delivery of
the intervention should be included. In a clinic-based disease management program, these
resources include time for all personnel involved directly or indirectly (eg, administrative
staff) in the delivery and maintenance of the program, supplies and equipment used,
facilities (for personnel or patients), and any incentives, materials, and transportation
services provided to patients (or caregivers) enrolled in the program. With a societal
perspective, patients’ and caregivers’ time associated with the program should also be
incorporated, including time spent participating in the program and time spent adhering to
interventions associated with program.27,31
To determine how fixed costs are handled requires determination of the time horizon of
interest. Time horizon can be classified into short and long depending on how costs for
various resources may change over time and with potential changes in volume. In the short
run, costs of administration (eg, support personnel) and capital (eg, facilities, equipment)
may be considered fixed costs in that costs for these resources may not be expected to
change in the near term or increase to a significant degree with the initiation of a small
disease management program. That does not mean, however, that these costs are zero. Over
the long run or with growth in the numbers of patients participating in the program,
administrative and facility costs would be expected to change and should be allocated to the
cost of the program.32
Upon identification of resources involved, each must be measured or estimated. With a
societal perspective, each of these resources should then be valued at their opportunity cost,
which is defined as the value of the resource in its next best use. The economic concept of
opportunity cost promotes standardization across interventions and allows for a fair
comparison of resources necessary to carry out different types of programs and treatments.
Market prices typically provide a good approximation of the opportunity cost for a resource.
In health care, however, prices (ie, charges) are sometimes inflated well beyond the
opportunity cost necessary to deliver a given service, and adjustments or other sources of
unit costs are necessary. However, from the perspective of a payer, charges are relevant.
And, from the perspective of a provider, accounting costs (ie, the amount paid for the
resources) are appropriate.
Development Process
In developing the TEAM-HF Costing Tool, we wished to design a user-friendly spreadsheet
program that would facilitate the systematic identification, enumeration, and valuation of
resources involved in the provision of patient-centered health care interventions (eg, disease
management programs, skills coping training, exercise training, home-based care).
Ultimately, we aimed to increase the validity and reliability of estimated program costs used
in published economic evaluations to increase comparability across studies for higher-
quality decision making. We recognized, however, that to maximize the utility of the
instrument for a wide range of users, the instrument had to be designed to derive cost
estimates that could represent the different study perspectives discussed above. We also
sought to develop a tool that could account for costs incurred by different types of programs,
in various settings, and for various health conditions.
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Throughout a series of drafts, we obtained feedback from an expert advisory panel
consisting of 2 academic nurse researchers, a community-based nurse practitioner with
expertise in disease management programs, a health economist, an academic cardiologist,
and a health policy expert.
Structure of the TEAM-HF Costing Tool
The TEAM-HF Costing Tool consists of a series of worksheets. The “Overview” worksheet
provides written documentation regarding the features and methods applied in the costing
tool. The second worksheet, “Description and Costing Options,” classifies the type of
patient-focused program being assessed and the options available for cost estimation. There
are 2 worksheets representing different strategies for deriving personnel costs, and 1
worksheet for each of the following types of resources: facilities, equipment, supplies/
incentives, and miscellaneous items. There is also a worksheet to estimate start-up costs and
another to document revenues or funding for the program. There are two results worksheets.
One summarizes total program costs and the other incorporates revenues to generate profit/
loss estimates. Finally, there are 2 worksheets that represent standardized and customized
unit costs that are assigned to itemized resources included in the preceding worksheets.
Incorporating the economic principles discussed above, the TEAM-HF Costing Tool was
developed as a Microsoft Excel application to facilitate adoption by a diverse array of users
for numerous potential purposes (Table 1). The tool includes a user manual and a separate
Excel-based questionnaire in which the user’s responses generate customized, printable
forms to guide data collection. The TEAM-HF Costing Tool and associated documents will
be available for download from the Internet at no cost to the user [http://team-hf.org].
Description and Costing Options—The TEAM-HF Costing Tool was developed to
estimate costs for 3 types of scenarios based on (1) whether patients participate in a given
program for a fixed period of time or indefinitely; and (2) whether the user wishes to
estimate costs for a fixed number of patients (eg, a cohort of 100 patients) or per unit of time
for a program that continues to enroll new participants (eg, annual cost per patient). Based
on the type of program selected, the required inputs vary (Table 2).
Personnel—Personnel typically account for the majority of costs in the provision of
behavioral or educational interventions. Personnel costs are estimated using 1 of the 2
methods: the top-down approach and the bottom-up approach. With the top-down approach,
users provide estimates of weekly time associated with the program. With the bottom-up
approach, users provide estimates of time spent by each type of personnel for each encounter
(eg, face-to-face session, telephone call).
Facility Costs—The “Facility Costs” worksheet is designed to estimate costs associated
with the physical locations required to provide the intervention (eg, office space, clinic
examination rooms). Users may choose to estimate facility costs using 1 of the 3 methods:
(1) fixed percentage based on personnel cost; (2) cost per square foot; and (3) an “off-the-
shelf” cost (Table 3). The off-the-shelf method is similar to the cost-per-square-foot
approach but uses standard estimates of square footage for different types of facilities (eg,
offices, examination rooms) to reduce user burden.
Equipment Costs—The “Equipment Costs” worksheet captures information on resources
used across multiple patients but not depleted during the delivery of the program (eg,
computers, software, office furniture). Costs for equipment are amortized over time to
represent the usable life of each resource.
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Supplies and Incentives—The “Supplies and Incentives” worksheet captures
information on resources that are depleted during the delivery of the program. Supplies
represent items given to individual patients, such as exercise equipment, medications, or
remote monitoring devices (eg, digital scales, handheld personal digital assistants), or used
in the provision of services to individual patients (eg, education materials, intravenous
diuretics, disposable medical equipment). Information on patient time and costs incurred by
patients (eg, parking, transportation) can be accounted for in this worksheet.
Miscellaneous Costs—The “Miscellaneous Costs” worksheet is designed to capture
costs not directly associated with the number of individuals enrolled in the program or the
number of encounters. Miscellaneous costs can include professional licensing fees,
professional training and travel, and other resources, such as subscriptions to medical
journals for staff involved in the program.
Start-up Costs—Start-up costs represent personnel costs and other resources or expenses
incurred before the program is initiated. Start-up costs could include costs associated with
training personnel, developing intervention materials, and advertising or other outreach
activities necessary to initiate the program. There is sometimes confusion between
equipment costs and start-up costs. For example, a software program designed to monitor
electronic devices for heart failure patients may be considered to be a start-up cost.
However, a purchased program should be captured as an equipment cost to be allocated
across individuals participating in the program over its expected duration of use.
Total Costs—The “Total Costs” worksheet provides tables summarizing resource-specific
and total costs on an annual and weekly basis for the program as a whole and for each
patient. Consistent with the other worksheets, cost estimates are provided using standardized
as well as customized units in separate worksheets containing unit prices and other
assumptions (eg, fringe benefit rates) necessary for cost estimation. The primary source for
salary and benefit information in the “Standardized Units” worksheet is the US Bureau of
Labor Statistics.33 Estimates regarding years of use for equipment were obtained from the
Internal Revenue Service.34
Pilot Testing
Upon development of the final draft of the costing tool, 4 individuals participated in pilot
testing: 3 from academic medical centers and 1 from a community setting. The participants
were asked to complete the costing tool for the disease management program they were
involved with or for a hypothetical disease management program. We allowed for
representation of a hypothetical program, because our primary interest was in assessing ease
of use and identifying areas where further clarification or modifications were needed rather
than developing accurate cost estimates from 4 disparate programs. To elicit structured
feedback, we developed a short survey for completion by each of the 4 individuals involved
in pilot testing.
Results
All 4 individuals who participated in pilot testing completed the written survey. Three out of
4 reported using the data collection forms. Two chose the “top-down” costing method and 2
chose the “bottom-up” method to estimate personnel costs. For estimating facility costs, all
participants chose the approach in which facility costs are based on a percentage of
personnel costs. Respondents agreed that the costing tool was clear, well formatted, and
followed a logical order.
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Comparison With Published Cost Estimates
To evaluate the extent to which the costing tool generates valid and reliable cost estimates,
we applied cost inputs and assumptions recently reported in an economic evaluation of HF-
ACTION, an exercise training program for patients with heart failure.9 We compared the
estimates generated by the TEAM-HF Costing Tool with estimates reported in the HF-
ACTION economic evaluation.
The exercise training protocol prescribed 3 sessions per patient per week across 12 weeks.
Patients completed, on average, 17.1 hours of exercise in 32.7 sessions, a mean of 31.4
minutes per session. In the HF-ACTION analysis, trainers supervised an average of 1.7
patients per session and spent an average of 35 minutes before and after each session on
associated activities, such as documentation in the medical record, billing, and scheduling.
Time was not explicitly recorded for sessions when patients failed to arrive. Details
regarding salaries for exercise physiologists, facility space, exercise equipment, and other
assumptions necessary to generate cost estimates were also reported in the appendix
accompanying the manuscript.9
To generate costs using the TEAM-HF Costing Tool, we selected the option representing the
program type as a “fixed duration per cohort - single cohort,” which is appropriate for
estimating costs in the setting of a clinical study (Figure). We then populated corresponding
cells to indicate that the program duration of 12 weeks and the cohort size of 14, consistent
with the 1159 patients enrolled in the exercise training arm distributed across 82 sites. To
derive personnel costs, we applied the “bottom-up” method, entering 66.4 minutes as the
time spent by exercise physiologists for each encounter. Although the costing tool was not
designed to account for group sessions, we accounted for the number of patients per session
by dividing 42 sessions per week by 1.7. Then, to account for the actual number of sessions
completed rather than prescribed, we multiplied by the ratio of completed to prescribed
sessions (ie, 32.7/36). To value each of the resources, we applied the standardized units
included in the costing tool and populated the “Customized Units” spreadsheet to
correspond to reported salaries, fringe benefit rates, rental rates, and equipment costs.
In the HF-ACTION economic evaluation,9 the direct total cost of supervised exercise
training was estimated at $632 per patient. Total costs for supervised exercise training
generated with the Costing Tool were $675 using standardized costs and assumptions built
into the tool. However, when we used the customizing features of the tool to apply unit costs
for salaries, fringe benefit rates, and other assumptions consistent with the HF-ACTION
analysis, the resulting cost estimate was $634 per patient (Figure).
Discussion
As the health care system evolves to address the needs of patients with chronic conditions,
new care management strategies are proliferating. Although most are patient-centered, they
are heterogeneous, differing with regard to the focus of the intervention (eg, medication
adherence, care coordination, exercise training), the mode of delivery (eg, home visits,
telephone, remote monitoring), targeted patient populations (eg, higher vs lower disease
severity, low income), frequency of contact, duration, and the types of health care providers
involved. Even among similar types of programs, comparisons of program costs currently
available in the literature are nearly impossible given the lack of methodological detail, the
wide range of costing strategies that could be applied, and variations in wage rates and other
costs across practice settings and geographic locations. To promote the generation of high-
quality cost estimates for informed decision making, we developed the TEAM-HF Costing
Tool for use by researchers, managers, and other professionals throughout the health care
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system and demonstrated its utility for computing costs associated with an exercise training
program.
The TEAM-HF Costing Tool can facilitate standardization of unit costs and assumptions for
estimating intervention costs for application in cost-effectiveness analyses. However,
choices used in the generation of the cost estimates must be consistent with economic
principles underpinning the design and execution of a cost-effectiveness analysis. The study
perspective and time horizon must be selected in accordance with the intended audience for
the analysis. With a societal perspective, a long-term time horizon is typically appropriate,
and analysts should include all program-related resources valued to approximate opportunity
costs. To facilitate comparisons across separate studies, we recommend the standardized
units incorporated in the costing tool. When a provider or payer perspective is chosen, the
user would be advised to apply customized units to generate meaningful and accurate cost
estimates. Also with regard to the use of cost estimates from the costing tool, cost-
effectiveness analyses can be carried out as a program-level analysis or a patient-level
analysis. In a program-level analysis, aggregated estimates of program costs would be paired
with aggregate estimates of clinical benefits relative to standard care. In a patient-level
analysis (eg, data from a randomized trial), disaggregated estimates of program costs, such
as the estimated cost per patient per week, could be applied to each patient based on the
number of weeks of participation in the program. Another benefit of the costing tool from a
research perspective is that use of standardized unit costs for salaries, facilities, and other
resources allows individual programs to publish study results while avoiding public
disclosure of confidential cost information. Finally, the availability of the tool promotes full
reporting of methodological approaches and assumptions applied in specific analyses,
thereby allowing readers to determine whether “apples-to-apples” comparisons are possible.
In addition to developing the TEAM-HF Costing Tool to facilitate standardization of costing
methods for use in economic evaluations, we recognized the need for a flexible tool that
could serve multiple potential uses for health care managers. To inform budgetary decisions,
health care managers can use the “Customized Units” spreadsheet to enter salaries and
benefits paid to employees, rental rates, supply costs, and other units to generate cost
estimates for the specific program at their site. Similarly, because the costing principles
integrated into the tool are generally accepted across countries, individuals outside the
United States could modify the inputs in the “Customized Units” worksheet to generate local
cost estimates for a given program.
Wide adoption of the TEAM-HF Costing Tool would lead to collection of cost estimates
across patient-focused programs. Since the development of the Drug Abuse Treatment Cost
Analysis Program (DATCAP) in early 1990s,35 the tool has been used by more than 110
programs to estimate costs for a range of treatment programs including prison-based,
residential, and outpatient programs.36 This compilation of cost estimates allowed for
publication of a set of cost bands for 8 treatment modalities to facilitate funding and
reimbursement decisions for substance abuse treatment.36 With adoption of the TEAM-HF
Costing Tool across a variety of users and dissemination of the resulting cost estimates,
similar cost bands could be developed for specific types of patient-focused interventions in
heart failure or other conditions.
Limitations
Although we aimed to develop a user-friendly costing system that is both flexible and
comprehensive, we cannot anticipate all user needs. As mentioned previously, it is important
to recognize that the system is not designed to evaluate the impact of programs on medical
costs stemming from reduced rehospitalization rates or other clinical outcomes. However,
we are in the process of developing another TEAM-HF tool to evaluate the cost-
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effectiveness of patient-focused programs specifically targeting patients with heart failure.
This tool will incorporate changes resulting from an intervention on patients’ clinical and
treatment characteristics to project downstream consequences on costs and quality-adjusted
survival. In addition, although we believe that incorporating standardized unit costs into the
TEAM-HF Costing Tool offers an advantage over costing systems developed for other uses,
no one set of standardized units will be appropriate for all programs. For example,
standardized unit costs for supplies such as blood pressure cuffs may reflect costs incurred
across a wide range of practices, while salaries for personnel may vary across locations and
settings. As the costing tool is adopted, we expect that users will point out which
standardized units are inappropriate and have a meaningful impact on estimated program
costs. As this information becomes available, future versions of the costing tool could be
updated to incorporate more suitable inputs. Also, unit costs will require updating over time.
We anticipate incorporating unit costs for future years and allowing the user to simply select
from a list representing years for which standardized unit costs are available.
We believe that researchers or program managers can successfully complete the costing tool
with the information available in the user manual. The amount of time required will depend
on the user’s choice to use the standardized or customized unit costs, the costing methods
selected, and the availability of information about the size of the program and provider time
spent on associated activities. Feedback from our pilot study suggests that a guided
introduction to the TEAM-HF Costing Tool would positively influence the extent to which it
is adopted by users. To promote its use, we are planning to provide training seminars at
regional and national professional meetings and to develop online training videos that will
be available when individuals are ready to begin using the tool. Lastly, we encourage
individuals to visit the TEAM-HF Web site for the costing tool and associated
documentation [link to be provided for publication].
Conclusion
The TEAM-HF Costing Tool can assist researchers and health care managers in the
generation of high-quality, comprehensive cost estimates of patient-centered interventions
that can be applied in economic evaluations and facilitate well-informed decision making for
internal budgeting, program planning, reimbursement negotiations, and improving the
efficiency of existing programs.
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Figure.
Excerpt From the TEAM-HF Costing Tool and Comparison of Findings With Published
Estimates From HF-ACTION
* assumed that costs for utilities and other overhead are included in the cost per square foot.
± costs for facilities and equipment were reported as ‘facility costs’ in the manuscript
reporting on results from the economic evaluation of HF-ACTION. 9
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Table 1
Potential Uses of the TEAM-HF Costing Tool
Potential Uses Explanation
Budgeting The tool can assist in annual budgeting in terms of estimating costs for specified numbers and types of
personnel, facilities, equipment, and other costs necessary to provide a patient-centered intervention.
Reimbursement negotiations The tool will allow the user to compare estimated costs to deliver the program with reimbursement rates
set by a given insurance company. The user may use the cost estimates generated with the tool to
negotiate for higher reimbursement rates.
Improve efficiency of an existing
program
The tool can be used to examine the cost impact of various program changes, such shortening time spent
per encounter, increasing volume of patients enrolled to allocate fixed costs (eg, facilities and
equipment) over a larger number of patients.
Cost-effectiveness evaluation The tool can be used to compute the average cost (per patient, per encounter) for the program that can be
used in a cost-effectiveness analysis designed to evaluate whether the intervention provides good value
for money if other scientifically sound principles of economic evaluation are followed.
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